Avanos Medical, Inc.
AVNS
$12.43
$0.373.07%
NYSE
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -3,883.81% | -- | 102.64% | -80.00% | -37.87% |
| Total Depreciation and Amortization | -3.48% | -- | -1.74% | -5.79% | -14.18% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 11,838.24% | -- | -90.50% | 288.89% | -168.00% |
| Change in Net Operating Assets | 862.71% | -- | 161.94% | -13.99% | -268.75% |
| Cash from Operations | 355.91% | -20.96% | 1,169.23% | -17.65% | -62.31% |
| Capital Expenditure | 18.64% | -- | -47.50% | -2.50% | -20.41% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -100.00% | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -109.38% | 75.46% | 9.23% | 50.00% | 1,753.06% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 71.74% | -- | 0.00% | 46.30% | -347.22% |
| Issuance of Common Stock | -- | -- | -- | -16.67% | -- |
| Repurchase of Common Stock | 98.44% | -- | -34.62% | -727.27% | -1,500.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | -- | -- | -- | -- |
| Cash from Financing | 76.11% | -134.26% | -21.95% | 96.83% | -423.74% |
| Foreign Exchange rate Adjustments | -362.50% | -- | 28.57% | -233.33% | -57.89% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 196.39% | -112.65% | 217.99% | 62.81% | -281.31% |